Tumor Necrosis Factor-Alpha and Adiponectin in Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma
出版年份 2023 全文链接
标题
Tumor Necrosis Factor-Alpha and Adiponectin in Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma
作者
关键词
-
出版物
Cancers
Volume 15, Issue 21, Pages 5306
出版商
MDPI AG
发表日期
2023-11-07
DOI
10.3390/cancers15215306
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Saroglitazar suppresses the hepatocellular carcinoma induced by intraperitoneal injection of diethylnitrosamine in C57BL/6 mice fed on choline deficient, l-amino acid- defined, high-fat diet
- (2023) Suresh R. Giri et al. BMC CANCER
- Therapeutic efficacy of liraglutide versus metformin in modulating the gut microbiota for treating type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease
- (2023) Xing Ying et al. Frontiers in Microbiology
- Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation
- (2023) Neda Yahoo et al. JOURNAL OF HEPATOLOGY
- Potential impact of trained innate immunity on the pathophysiology of metabolic dysfunction-associated fatty liver disease
- (2023) Jannis Kountouras et al. CLINICAL IMMUNOLOGY
- Decoding the role of leptin and adiponectin in obesity-related gastrointestinal cancer
- (2023) Vanda Marques et al. CLINICAL SCIENCE
- Nonalcoholic fatty liver disease and hepatocellular carcinoma:Insights in epidemiology, pathogenesis, imaging, prevention and therapy
- (2023) Stergios A. Polyzos et al. SEMINARS IN CANCER BIOLOGY
- The Role of Tumor Necrosis Factor-Alpha in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease
- (2023) Ilias D. Vachliotis et al. Current Obesity Reports
- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- T cells: Friends and foes in NASH pathogenesis and hepatocarcinogenesis
- (2022) Pierluigi Ramadori et al. HEPATOLOGY
- TNF in the liver: targeting a central player in inflammation
- (2022) Gisa Tiegs et al. Seminars in Immunopathology
- Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link
- (2022) Lampros Chrysavgis et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Metformin treatment rescues CD8+ T cell response to immune checkpoint inhibitor therapy in mice with NAFLD
- (2022) Simon Wabitsch et al. JOURNAL OF HEPATOLOGY
- Adiponectin and the risk of gastrointestinal cancers in East Asians: Mendelian randomization analysis
- (2022) Hua Jiang et al. Cancer Medicine
- Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease
- (2022) Yamei Duan et al. Frontiers in Immunology
- Targeting TNFR2: A Novel Breakthrough in the Treatment of Cancer
- (2022) Muchun Li et al. Frontiers in Oncology
- Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver Disease
- (2022) Stergios A. Polyzos et al. Current Obesity Reports
- Review article: the epidemiologic burden of non‐alcoholic fatty liver disease across the world
- (2022) Linda Henry et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Metformin modulate immune fitness in hepatocellular carcinoma: Molecular and cellular approach
- (2022) Eslam E. Abd El-Fattah et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma
- (2022) Meenakshi Vachher et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Combination Therapies for Nonalcoholic Fatty Liver Disease
- (2022) Evangelia S. Makri et al. Journal of Personalized Medicine
- NASH and Hepatocellular Carcinoma: Immunology and Immunotherapy
- (2022) Matthias Pinter et al. CLINICAL CANCER RESEARCH
- Metformin keeps CD8+ T cells active and moving in NASH-HCC immunotherapy
- (2022) Amaia Lujambio et al. JOURNAL OF HEPATOLOGY
- Liraglutide enhances the effect of checkpoint blockade through the inhibition of neutrophil extracellular traps in murine lung and liver cancers
- (2022) Duo Chen et al. FEBS Open Bio
- The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers
- (2022) Qing Tang et al. Frontiers in Immunology
- Metformin in patients with hepatocellular carcinoma receiving immunotherapy
- (2022) Huapeng Lin et al. JOURNAL OF HEPATOLOGY
- Elevation of circulating TNF receptor 2 in cancer: A systematic meta-analysis for its potential as a diagnostic cancer biomarker
- (2022) Apriliana E. R. Kartikasari et al. Frontiers in Immunology
- Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace
- (2022) Krizia Pocino et al. Journal of Personalized Medicine
- Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines
- (2021) A. Vogel et al. ANNALS OF ONCOLOGY
- Effects of Metformin on Hepatic Steatosis in Adults with Nonalcoholic Fatty Liver Disease and Diabetes: Insights from the Cellular to Patient Levels
- (2021) Kanokwan Pinyopornpanish et al. Gut and Liver
- Metformin Actions on the Liver: Protection Mechanisms Emerging in Hepatocytes and Immune Cells against NASH-Related HCC
- (2021) Yueqi Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- NASH limits anti-tumour surveillance in immunotherapy-treated HCC
- (2021) Dominik Pfister et al. NATURE
- Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH
- (2021) Michael Dudek et al. NATURE
- Biomarkers of Oncogenesis, Adipose Tissue Dysfunction and Systemic Inflammation for the Detection of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
- (2021) Gian Paolo Caviglia et al. Cancers
- Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease
- (2021) Luca Valenti et al. DIGESTIVE AND LIVER DISEASE
- Sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease
- (2021) Evangelia S. Makri et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002–2020)
- (2021) Philipp K. Haber et al. GASTROENTEROLOGY
- Thiazolidinediones and Glucagon‐Like Peptide‐1 Receptor Agonists and the Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study
- (2021) Judith Dalem et al. HEPATOLOGY
- Circulating tumor necrosis factor‐α levels in non‐alcoholic fatty liver disease: A systematic review and a meta‐analysis
- (2021) Victoria Potoupni et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Tumor necrosis factor-α signaling in nonalcoholic steatohepatitis and targeted therapies
- (2021) Sijia Lu et al. Journal of Genetics and Genomics
- Impact of Incretin-Based Therapies on Adipokines and Adiponectin
- (2021) Habib Yaribeygi et al. Journal of Diabetes Research
- Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis
- (2021) Rasoul Akbari et al. BMC Pharmacology & Toxicology
- Viral Status and Efficacy of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis
- (2021) Ziniu Ding et al. Frontiers in Immunology
- The Role of Cytokines in the Different Stages of Hepatocellular Carcinoma
- (2021) Noe Rico Montanari et al. Cancers
- BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
- (2021) Maria Reig et al. JOURNAL OF HEPATOLOGY
- Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis
- (2020) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Adipocytes promote tumor progression and induce PD-L1 expression via TNF-α/IL-6 signaling
- (2020) Zhi Li et al. Cancer Cell International
- Viral status, immune microenvironment and immunological response to checkpoint inhibitors in hepatocellular carcinoma
- (2020) Won Jin Ho et al. Journal for ImmunoTherapy of Cancer
- Immunological distinctions between nonalcoholic steatohepatitis and hepatocellular carcinoma
- (2020) Seo-Young Koo et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Glucagon-Like Peptide-1 Receptor Agonist Prevented the Progression of Hepatocellular Carcinoma in a Mouse Model of Nonalcoholic Steatohepatitis
- (2020) Motoyasu Kojima et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease
- (2020) Evangelia Makri et al. ARCHIVES OF MEDICAL RESEARCH
- The association of leptin and adiponectin with hepatocellular carcinoma risk and prognosis: a combination of traditional, survival, and dose-response meta-analysis
- (2020) Lilong Zhang et al. BMC CANCER
- Association between five types of Tumor Necrosis Factor-α gene polymorphism and hepatocellular carcinoma risk: a meta-analysis
- (2020) Citrawati Dyah Kencono Wungu et al. BMC CANCER
- Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
- (2020) Daniel Q. Huang et al. Nature Reviews Gastroenterology & Hepatology
- Hepatokines and adipokines in NASH-related hepatocellular carcinoma
- (2020) Ozlem Kucukoglu et al. JOURNAL OF HEPATOLOGY
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets
- (2019) Yoon Yang et al. SEMINARS IN LIVER DISEASE
- Non-alcoholic fatty liver disease treatment in patients with type 2 diabetes mellitus; new kids on the block
- (2019) Vasilios G. Athyros et al. Current Vascular Pharmacology
- TNF-α derived from M2 tumor-associated macrophages promotes epithelial-mesenchymal transition and cancer stemness through the Wnt/β-catenin pathway in SMMC-7721 hepatocellular carcinoma cells
- (2019) Yongxu Chen et al. EXPERIMENTAL CELL RESEARCH
- Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy
- (2019) Elisabeth Perez-Ruiz et al. NATURE
- From NASH to HCC: current concepts and future challenges
- (2019) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- The high expression of TNF-α and NF-κB in tumor microenvironment predicts good prognosis of patients with BCLC-0-B hepatocellular carcinoma
- (2019) Haoran Li et al. Translational Cancer Research
- Insights into the success and failure of systemic therapy for hepatocellular carcinoma
- (2019) Jordi Bruix et al. Nature Reviews Gastroenterology & Hepatology
- The TNF Paradox in Cancer Progression and Immunotherapy
- (2019) Anne Montfort et al. Frontiers in Immunology
- Targeting p53/TRAIL/caspase-8 signaling by adiponectin reverses thioacetamide-induced hepatocellular carcinoma in rats
- (2019) Entsar A. Nazmy et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- The SGLT2 Inhibitor Canagliflozin Prevents Carcinogenesis in a Mouse Model of Diabetes and Non-Alcoholic Steatohepatitis-Related Hepatocarcinogenesis: Association with SGLT2 Expression in Hepatocellular Carcinoma
- (2019) Teruo Jojima et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tumor necrosis factor-α promotes hepatocellular carcinogenesis through the activation of hepatic progenitor cells
- (2018) Yingying Jing et al. CANCER LETTERS
- The immunology of hepatocellular carcinoma
- (2018) Marc Ringelhan et al. NATURE IMMUNOLOGY
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Regulatory Role of Apoptosis Antagonizing Transcription Factor in the Pathogenesis of NAFLD and HCC
- (2018) Divya P. Kumar et al. HEPATOLOGY
- Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
- (2018) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Obesity and cancer risk: Emerging biological mechanisms and perspectives
- (2018) Konstantinos I. Avgerinos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma
- (2018) Wenliang Tan et al. EBioMedicine
- Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale
- (2017) Andrea Casadei Gardini et al. EUROPEAN JOURNAL OF CANCER
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP–PKA–EGFR–STAT3 axis
- (2017) M Zhou et al. ONCOGENE
- TNFR2: A Novel Target for Cancer Immunotherapy
- (2017) Éva S. Vanamee et al. TRENDS IN MOLECULAR MEDICINE
- Chemopreventive and hepatoprotective roles of adiponectin (SULF2 inhibitor) in hepatocelluar carcinoma
- (2016) Mohammed M.H. Al-Gayyar et al. BIOLOGICAL CHEMISTRY
- Relationship of Serum Adiponectin Levels and Metformin Therapy in Patients with Type 2 Diabetes
- (2016) J.-R. Su et al. HORMONE AND METABOLIC RESEARCH
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Adipokines in nonalcoholic fatty liver disease
- (2016) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Circulating adiponectin levels in various malignancies: an updated meta-analysis of 107 studies
- (2016) Tai Wei et al. Oncotarget
- Prognostic and Therapeutic Values of Tumor Necrosis Factor-Alpha in Hepatocellular Carcinoma
- (2016) Hongmei Wang et al. MEDICAL SCIENCE MONITOR
- Serum Adiponectin Is Associated with Worsened Overall Survival in a Prospective Cohort of Hepatocellular Carcinoma Patients
- (2014) Abby B. Siegel et al. ONCOLOGY
- Adiponectin Receptor Expression Predicts Favorable Prognosis in Cases of Hepatocellular Carcinoma
- (2014) Eun Shin et al. PATHOLOGY & ONCOLOGY RESEARCH
- Obesity, adipokines and hepatocellular carcinoma
- (2013) Xiao-Feng Duan et al. INTERNATIONAL JOURNAL OF CANCER
- Increased adiponectin associated with poor survival in hepatocellular carcinoma
- (2013) Shen-Nien Wang et al. JOURNAL OF GASTROENTEROLOGY
- A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity
- (2013) Miki Okada-Iwabu et al. NATURE
- Editorial [Hot Topic Adiponectin in Health and Disease: Current Evidence and Therapeutic Perspectives (Guest Editor: Stergios A. Polyzos)]
- (2012) Stergios A. Polyzos CURRENT MEDICINAL CHEMISTRY
- TNF-Dependent Signaling Pathways in Liver Cancer: Promising Targets for Therapeutic Strategies?
- (2012) Christoph Roderburg et al. DIGESTIVE DISEASES
- Adipocytokines and Hepatocellular Carcinoma
- (2012) Verena Wieser et al. DIGESTIVE DISEASES
- The significance of serum levels of adiponectin, leptin, and hyaluronic acid in hepatocellular carcinoma of cirrhotic and noncirrhotic patients
- (2012) N A H Sadik et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- Nonalcoholic Fatty Liver Disease
- (2012) Stergios A. Polyzos et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- TNF signaling drives myeloid-derived suppressor cell accumulation
- (2012) Xueqiang Zhao et al. JOURNAL OF CLINICAL INVESTIGATION
- Role of cytokines and chemokines in non-alcoholic fatty liver disease
- (2012) Vincent Braunersreuther WORLD JOURNAL OF GASTROENTEROLOGY
- Adiponectin in non-alcoholic fatty liver disease treatment: therapeutic perspectives and unresolved dilemmas
- (2011) S. A. Polyzos et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Molecular mechanisms of signal transduction via adiponectin and adiponectin receptors
- (2010) John T. Heiker et al. BIOLOGICAL CHEMISTRY
- Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
- (2010) Eek Joong Park et al. CELL
- Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia
- (2010) P. Matafome et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Adiponectin Modulates C-Jun N-Terminal Kinase and Mammalian Target of Rapamycin and Inhibits Hepatocellular Carcinoma
- (2010) Neeraj K. Saxena et al. GASTROENTEROLOGY
- Adiponectin as a potential therapeutic agent for nonalcoholic steatohepatitis
- (2010) HEPATOLOGY RESEARCH
- Nonlinear Distribution of Adiponectin in Patients With Nonalcoholic Fatty Liver Disease Limits Its Use in Linear Regression Analysis
- (2010) Stergios Alexandros Polyzos et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: The two sides of the same coin
- (2010) Stergios A. Polyzos et al. MEDICAL HYPOTHESES
- Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis
- (2010) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Nonalcoholic Fatty Liver Disease: The Pathogenetic Roles of Insulin Resistance and Adipocytokines
- (2009) Stergios Polyzos et al. CURRENT MOLECULAR MEDICINE
- The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease
- (2009) Stergios A. Polyzos et al. DIABETES OBESITY & METABOLISM
- Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis
- (2009) Takeharu Asano et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started